Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.

Daniel W. Lin, MD, reviews new guidance on using MRI, biomarkers, and more, to improve the detection of prostate cancer.

Only about 6% of men have had a documented discussion with their primary care doctor about prostate cancer screening, even ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

Prostate cancer screening is essential for early detection, especially in high-risk groups like men over 50, African Americans, and those with a family history. Routine screening, including PSA tests ...

A next-generation Stockholm3 blood test detected aggressive prostate cancer more accurately than PSA, improving early ...

Here’s what actually happens during a prostate cancer screening - About 160 men are diagnosed with prostate cancer every day ...

The Korean Urological Oncology Society (President Jeong Byeong-chang) held a press conference at the Korea Press Center on ...